It is a pharma limited liability partnership based in Faridabad, Haryana, India, established in 2020.
2020 | Faridabad, Haryana, India | ActiveNucleosomecare Pharma Llp, a active limited liability partnership, was established on 22 October 2020 in Faridabad, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAU-3689. Registered under ROC Roc Delhi. It has total obligation of contribution of ₹0.10 M.
Its leadership includes Kiran Srivastava (Designated Partner), Pooja Srivastava (Designated Partner). Past directors included Ved Prakash Sharma. Its latest date of accounts and solvency statement 31 March 2024. It is based at D 214, Second Floor, Sector 81 Puri 81 High Street, Faridabad, Haryana, 121001.
AAU-3689
22 October 2020
₹0.10 M
Roc Delhi
Active
Explore comprehensive insights into Nucleosomecare Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Srivastava | Designated Partner | 22 Oct 2020 | Current |
| Pooja Srivastava | Designated Partner | 21 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Designated Partner | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Nucleosomecare Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Nucleosomecare Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Nucleosomecare Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nucleosomecare Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleosomecare Pharma Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nucleosomecare Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.
The activity Nucleosomecare Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Pooja Srivastava was appointed as a Designated Partner was appointed as a Designated Partner on 21 Mar 2023 & has been associated with this company since 2 years 9 months . was completed.
Kiran Srivastava was appointed as a Designated Partner was appointed as a Designated Partner on 22 Oct 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Nucleosomecare Pharma Llp was registered on 22 Oct 2020 with Roc Delhi & aged 5 years 2 months as per MCA records. was recorded as a recent event.
The LLPIN of Nucleosomecare Pharma Llp is AAU-3689.
Nucleosomecare Pharma Llp is headquartered at D 214, Second Floor, Sector 81 Puri 81 High Street, Faridabad, Haryana, 121001.
Nucleosomecare Pharma Llp was incorporated on 22 October 2020.
The current directors of Nucleosomecare Pharma Llp are
The primary industry of Nucleosomecare Pharma Llp is Pharma.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX